this 5-year prospective study of ophthalmologic findings in 1299 patients treated with oral 8-methoxypsoralen photochemotherapy ( puva ) for psoriasis failed to demonstrate a significant dose-dependent increase in the risk of developing symptomatic cataracts .
C0025684
8-methoxypsoralen
C0033860
psoriasis